Nifty

:

23477.80

Sensex

:

74902.59

46.30 (0.20%)
138.36 (0.19%)

Login

Nifty
Sensex

:
:

23477.80
74902.59

46.30 (0.20%)
138.36 (0.19%)

Bajaj Healthcare Ltd.

Pharmaceuticals & Drugs - API

Rating :

48/99

BSE: 539872 | NSE: BAJAJHCARE

Watchlist

NSE BSE

333.30

10-Sep-2026

Open
High
Low
Previous Close

335.9
337.9
331.5
333.70

Volume
Traded Value (lacs)
52 Week High
52 Week Low

62427
20895070.75
515.9
272.35

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,121.72
48.72
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,317.20
0.45%
2.05

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.42
-2.11
8.88

EBITDA CAGR (%)

10 Years
5 Years
3 Years

13.02
-2.43
6.56

PAT CAGR (%)

10 Years
5 Years
3 Years

10.54
-21.48
-

P:E (Median)

8 Years
5 Years
3 Years

16.88
17.09
27.63

P:BV (Average)

8 Years
5 Years
3 Years

3.27
3.04
3.05

EV:EBITDA (Average)

8 Years
5 Years
3 Years

11.74
13.33
15.58

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 165.63 148.84 11.28% 153.06 154.47 -0.91% 161.22 122.79 31.30% 147.92 133.09 11.14%
Expenses 136.88 124.33 10.09% 130.38 142.72 -8.65% 130.54 101.15 29.06% 120.97 108.57 11.42%
EBITDA 28.75 24.51 17.30% 22.68 11.76 92.86% 30.68 21.64 41.77% 26.95 24.52 9.91%
EBIDTM 17.36% 16.47% 14.82% 7.61% 19.03% 17.62% 18.22% 18.43%
Other Income 0.81 0.88 -7.95% 2.96 13.57 -78.19% 1.65 2.37 -30.38% 1.65 2.61 -36.78%
Interest 6.09 5.23 16.44% 5.57 6.08 -8.39% 5.88 5.51 6.72% 5.56 7.88 -29.44%
Depreciation 7.01 5.64 24.29% 7.63 7.53 1.33% 7.20 6.85 5.11% 7.08 6.81 3.96%
PBT 16.46 14.53 13.28% -20.81 11.72 - 19.24 11.65 65.15% 15.96 12.45 28.19%
Tax 2.57 2.35 9.36% -1.40 0.13 - 3.14 -3.31 - 3.51 4.10 -14.39%
PAT 13.89 12.18 14.04% -19.41 11.59 - 16.10 14.97 7.55% 12.45 8.34 49.28%
PATM 8.39% 8.18% -12.68% 7.50% 9.99% 12.19% 8.42% 6.27%
EPS 4.12 3.61 14.13% -5.76 3.44 - 4.78 4.44 7.66% 3.69 2.48 48.79%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 627.83 611.03 542.60 473.42 645.80 679.89 656.98 410.01 325.02 289.51 207.24 Net Sales Growth 12.27% 12.61% 14.61% -26.69% -5.01% 3.49% 60.24% 26.15% 12.27% 39.70% Cost Of Goods Sold 321.91 316.40 286.45 254.77 382.78 406.14 377.89 263.23 196.87 177.68 111.23 Gross Profit 305.92 294.64 256.16 218.65 263.01 273.75 279.09 146.78 128.15 111.83 96.01 GP Margin 48.73% 48.22% 47.21% 46.19% 40.73% 40.26% 42.48% 35.80% 39.43% 38.63% 46.33% Total Expenditure 518.77 506.13 460.03 397.08 534.32 561.23 520.62 361.73 282.09 250.08 176.40 Power & Fuel Cost - 31.48 22.77 31.47 37.69 31.83 24.96 24.24 21.83 19.81 16.79 % Of Sales - 5.15% 4.20% 6.65% 5.84% 4.68% 3.80% 5.91% 6.72% 6.84% 8.10% Employee Cost - 62.75 57.06 43.85 42.32 41.11 34.55 28.18 24.62 21.65 19.57 % Of Sales - 10.27% 10.52% 9.26% 6.55% 6.05% 5.26% 6.87% 7.57% 7.48% 9.44% Manufacturing Exp. - 50.23 59.37 38.89 34.11 59.68 64.02 28.56 25.07 21.53 19.89 % Of Sales - 8.22% 10.94% 8.21% 5.28% 8.78% 9.74% 6.97% 7.71% 7.44% 9.60% General & Admin Exp. - 18.06 12.30 10.55 11.08 12.74 11.03 7.95 6.64 5.06 5.76 % Of Sales - 2.96% 2.27% 2.23% 1.72% 1.87% 1.68% 1.94% 2.04% 1.75% 2.78% Selling & Distn. Exp. - 20.10 18.91 14.57 19.09 3.91 4.17 1.28 1.77 1.64 1.26 % Of Sales - 3.29% 3.49% 3.08% 2.96% 0.58% 0.63% 0.31% 0.54% 0.57% 0.61% Miscellaneous Exp. - 7.10 3.17 2.99 7.25 5.81 4.00 8.28 5.29 2.70 1.26 % Of Sales - 1.16% 0.58% 0.63% 1.12% 0.85% 0.61% 2.02% 1.63% 0.93% 0.92% EBITDA 109.06 104.90 82.57 76.34 111.48 118.66 136.36 48.28 42.93 39.43 30.84 EBITDA Margin 17.37% 17.17% 15.22% 16.13% 17.26% 17.45% 20.76% 11.78% 13.21% 13.62% 14.88% Other Income 7.07 7.13 19.40 8.69 1.59 1.44 6.91 6.53 0.97 2.07 2.39 Interest 23.10 22.31 28.06 29.75 17.68 12.78 8.34 6.63 8.32 7.73 8.20 Depreciation 28.92 27.55 27.92 27.62 17.21 17.64 16.12 12.12 11.41 11.08 11.35 PBT 30.85 62.17 46.01 27.65 78.18 89.68 118.82 36.06 24.17 22.68 13.69 Tax 7.82 7.61 3.08 -2.35 14.65 18.30 35.71 10.82 7.86 7.50 5.87 Tax Rate 25.35% 26.31% 6.69% 14.09% 18.74% 20.41% 30.05% 30.01% 32.52% 33.07% 42.88% PAT 23.03 21.31 42.93 -14.33 63.53 71.39 83.11 25.24 16.31 15.19 7.82 PAT before Minority Interest 23.03 21.31 42.93 -14.33 63.53 71.39 83.11 25.24 16.31 15.19 7.82 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.67% 3.49% 7.91% -3.03% 9.84% 10.50% 12.65% 6.16% 5.02% 5.25% 3.77% PAT Growth -51.08% -50.36% - - -11.01% -14.10% 229.28% 54.75% 7.37% 94.25% EPS 6.83 6.32 12.74 -4.25 18.85 21.18 24.66 7.49 4.84 4.51 2.32

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 533.00 466.16 278.36 367.69 328.49 258.41 177.93 129.11 113.61 99.00 Share Capital 16.83 15.79 13.80 13.80 13.80 13.80 13.80 6.90 6.90 6.90 Total Reserves 515.16 432.80 264.56 353.89 314.69 244.61 164.13 122.21 106.71 92.10 Non-Current Liabilities 56.73 51.00 23.43 96.37 70.54 84.65 27.40 20.41 23.45 27.69 Secured Loans 47.57 64.67 38.58 93.66 66.31 79.71 22.97 16.19 19.80 24.41 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.60 1.20 1.68 2.43 Long Term Provisions 7.18 4.98 6.14 1.45 2.67 2.78 2.08 1.42 0.77 0.00 Current Liabilities 309.91 272.27 402.11 435.23 322.07 182.57 137.61 117.34 131.07 92.55 Trade Payables 115.28 99.84 89.43 84.75 104.92 68.95 57.48 29.98 43.38 18.85 Other Current Liabilities 29.84 37.32 51.07 47.55 31.44 24.98 21.18 25.62 25.93 20.02 Short Term Borrowings 163.76 133.84 261.48 289.42 176.20 88.47 58.43 54.89 54.52 39.16 Short Term Provisions 1.02 1.26 0.12 13.51 9.51 0.18 0.52 6.84 7.25 14.52 Total Liabilities 899.64 789.43 703.90 899.29 721.10 525.63 342.94 266.86 268.13 219.24 Net Block 248.21 238.45 252.75 365.69 269.74 208.13 162.24 128.50 126.62 127.93 Gross Block 472.69 436.47 422.98 525.01 401.73 329.25 267.83 222.23 209.65 199.88 Accumulated Depreciation 224.49 198.02 170.23 159.32 131.99 121.13 105.59 93.74 83.03 71.95 Non Current Assets 273.55 250.38 263.22 397.26 322.79 267.30 174.53 129.68 128.59 128.16 Capital Work in Progress 7.94 3.45 6.62 21.73 51.98 57.05 5.45 1.18 1.97 0.23 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 5.00 0.00 0.00 0.00 Long Term Loans & Adv. 3.71 5.73 1.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 13.70 2.75 2.70 9.84 1.07 2.12 1.84 0.00 0.00 0.00 Current Assets 569.08 488.26 404.54 502.04 398.31 258.33 168.42 137.17 139.55 91.08 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 216.01 161.89 144.04 208.79 159.26 97.11 39.28 30.05 33.66 16.76 Sundry Debtors 233.85 251.67 180.24 194.17 184.51 98.88 98.48 78.13 80.38 52.69 Cash & Bank 37.99 6.67 2.93 19.23 1.98 14.24 4.16 7.86 8.29 0.84 Other Current Assets 81.23 35.49 37.28 35.58 52.56 48.10 26.50 21.13 17.21 20.79 Short Term Loans & Adv. 69.01 32.54 40.06 44.27 14.97 16.10 13.13 18.79 14.98 18.19 Net Current Assets 259.17 216.00 2.43 66.80 76.24 75.76 30.80 19.83 8.47 -1.47 Total Assets 842.63 738.64 667.76 899.30 721.10 525.63 342.95 266.85 268.14 219.24

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 58.08 21.62 92.29 -22.19 0.69 43.56 20.57 25.17 16.61 22.12 PBT 23.81 42.00 -103.87 58.22 89.68 118.82 36.06 24.17 22.68 13.69 Adjustment 80.06 46.42 169.79 55.89 31.47 24.48 15.54 20.06 18.77 19.32 Changes in Working Capital -47.81 -62.21 39.15 -124.76 -110.84 -64.09 -21.91 -6.04 -18.88 -5.81 Cash after chg. in Working capital 56.06 26.21 105.08 -10.66 10.32 79.21 29.70 38.19 22.58 27.20 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 2.02 -4.59 -12.79 -11.54 -9.63 -35.65 -9.12 -13.02 -5.96 -5.08 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -47.78 -14.82 -11.24 -93.43 -74.80 -108.93 -27.56 -13.03 -11.64 -8.45 Net Fixed Assets -40.71 -10.32 117.14 -93.03 -67.41 -113.02 -49.87 -11.79 -11.51 -7.26 Net Investments 0.00 0.00 0.00 0.00 0.00 5.00 -5.00 0.00 0.00 0.00 Others -7.07 -4.50 -128.38 -0.40 -7.39 -0.91 27.31 -1.24 -0.13 -1.19 Cash from Financing Activity 24.33 -6.38 -96.60 131.37 61.85 75.46 3.28 -12.57 2.47 -13.20 Net Cash Inflow / Outflow 34.63 0.43 -15.55 15.75 -12.27 10.08 -3.70 -0.42 7.45 0.47 Opening Cash & Equivalents 2.60 2.17 17.72 1.98 14.24 4.16 7.86 8.29 0.84 0.36 Closing Cash & Equivalent 37.24 2.60 2.17 17.72 1.98 14.24 4.16 7.86 8.29 0.84

Financial Ratios

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 158.04 142.04 100.86 133.23 119.02 93.63 64.47 64.41 52.73 71.74 ROA 2.47% 5.51% -1.74% 7.84% 11.45% 19.14% 8.28% 6.10% 6.23% 3.65% ROE 4.35% 11.81% -4.44% 18.25% 24.33% 38.09% 18.92% 20.18% 17.68% 10.77% ROCE 7.04% 11.40% 1.88% 14.02% 20.00% 35.91% 19.47% 19.75% 18.25% 14.52% Fixed Asset Turnover 1.34 1.26 1.00 2.79 1.86 2.20 1.67 1.71 1.60 1.18 Receivable days 145.02 145.27 144.33 53.51 76.07 54.82 78.61 78.15 74.24 75.67 Inventory Days 112.87 102.90 136.01 52.00 68.82 37.89 30.86 31.41 28.13 28.80 Payable days 124.08 120.59 124.77 90.43 78.13 61.06 43.87 46.86 44.67 35.97 Cash Conversion Cycle 133.80 127.58 155.57 15.08 66.76 31.65 65.59 62.70 57.71 68.50 Total Debt/Equity 0.44 0.50 1.19 1.13 0.78 0.70 0.51 0.91 1.19 0.76 Interest Cover 2.30 2.64 0.44 5.42 8.02 15.25 6.44 3.91 3.93 2.67

Top Investors:

deepak ramanlal joshi

hdfc mutual fund - hdfc pharma and healthcare fund

Annual Reports:

News Update:

Bajaj Healthcare gets DCGI approval to manufacture, market Cenobamate API, Tablets
13th Aug 2026, 13:05 PM

Cenobamate is a next-generation antiseizure medication indicated for the treatment of partial-onset seizures in adults
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback